Back
Speaker illustration

Mrs Andree Levorsen

(Norway)

Presentations

Comparative effectiveness and costs of enoxaparin versus unfractionated heparin in treating acute coronary syndrome

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session: Acute Coronary Syndromes - P2Y12 inhibitor

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources